Consensus Albemarle Corporation

Stocks

ALB

US0126531013

Specialty Chemicals

Real-time Estimate Cboe BZX 20:23:42 06/11/2026 GMT			5-day change	1st Jan Change
99.52 ^USD	+1.17%		+9.15%	-29.77%

02:13pm	RBC Lowers Price Target on Albemarle to $119 From $129, Keeps Outperform Rating	MT
11-05	Albemarle swings to third-quarter profit on rising lithium prices	RE

Evolution of the Average Target: Albemarle Corporation

Evolution of the Target Price: Albemarle Corporation

Changes in Analyst Recommendations: Albemarle Corporation

630e8b.hURWuRn2SgFt8sLRcPQzF6Grd-qWJ8q9zewFOI65PIk._H0_9kGzB1EmwI6_FaVEf-XAG8fdfvPtnZlLcd_oDLDMAj7XX6U9aR6LrQ~bcdce75a5faf869c3a4faeae51984535

Analysts' recommendations: Albemarle Corporation

02:13pm	RBC Lowers Price Target on Albemarle to $119 From $129, Keeps Outperform Rating	MT
11-03	Rothschild & Co Redburn Adjusts Price Target on Albemarle to $100 From $170	MT
10-30	Analyst recommendations: GE Vernova, Intel, Reddit, Caterpillar, Crocs…
10-21	Citigroup Adjusts Price Target on Albemarle to $125 From $175	MT
10-19	BofA Securities Adjusts Albemarle Price Target to $131 From $155, Maintains Buy Rating	MT
10-15	RBC Cuts Price Target on Albemarle to $129 From $157, Keeps Outperform Rating	MT
10-14	Mizuho Securities Upgrades Albemarle to Buy From Neutral, $130 Price Target	MT
10-14	Baird Adjusts Price Target on Albemarle to $123 From $157	MT
10-14	Analyst recommendations: Albemarle, Dell Technologies, Domino's Pizza, Broadcom…
10-13	Barclays Initiates Albemarle at Equalweight With $109 Price Target	MT
10-06	BMO Capital Adjusts Price Target on Albemarle to $175 From $200, Keeps Outperform Rating	MT
10-05	UBS Adjusts Albemarle Price Target to $150 From $175, Maintains Buy Rating	MT
10-01	Mizuho Cuts Price Target on Albemarle to $130 From $140, Keeps Neutral Rating	MT
10-01	Mizuho Adjusts Price Target on Albemarle to $130 From $140, Maintains Neutral Rating	MT
09-18	Mizuho Securities Adjusts Albemarle Price Target to $140 From $160, Maintains Neutral Rating	MT
08-10	Albemarle to Benefit From Low-cost Assets, Brownfield Opportunity, RBC Says	MT
08-10	Scotiabank Adjusts Albemarle PT to $190 From $200, Maintains Sector Outperform Rating	MT
08-10	RBC Capital Adjusts Price Target on Albemarle to $157 From $166, Keeps Outperform Rating	MT
08-10	Morgan Stanley Adjusts Price Target on Albemarle to $161 From $189, Keeps Equalweight Rating	MT
08-07	Baird Adjusts Albemarle Price Target to $157 From $178	MT
08-07	Citigroup Adjusts Albemarle Price Target to $175 From $225	MT
08-07	BMO Capital Adjusts Albemarle Price Target to $200 From $250	MT
08-07	UBS Adjusts Price Target on Albemarle to $175 From $205, Maintains Buy Rating	MT
07-27	Scotiabank Adjusts Price Target on Albemarle to $200 From $215, Maintains Sector Outperform Rating	MT
07-23	HSBC Adjusts Price Target on Albemarle to $170 From $230, Maintains Buy Rating	MT

More recommendations

Other Specialty Chemicals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALBEMARLE CORPORATION					+57.24%
	ECOLAB INC.					+8.09%
	GIVAUDAN SA					-10.38%
	SIKA AG					+8.52%
	HENKEL AG & CO. KGAA					-5.73%
	NOVONESIS A/S					+4.4%
	FUJIFILM HOLDINGS CORPORATION					+14.61%
	EMS-CHEMIE HOLDING AG					-11.23%
	DUPONT DE NEMOURS, INC.					+15.84%
	SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.					+44.81%
	Average					+12.62%
	Weighted average by Cap.					+6.74%